Document Detail


Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management.
MedLine Citation:
PMID:  23136035     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Idiopathic intracranial hypertension (IIH, pseudotumor cerebri) is a syndrome of elevated intracranial pressure of unknown cause that occurs predominantly in obese women of childbearing age. It is a diagnosis of exclusion and, therefore, other causes of increased intracranial pressure must be sought with history, imaging, and cerebrospinal fluid examination before the diagnosis can be made. IIH produces symptoms and signs of increased intracranial pressure, including papilledema. If untreated, papilledema can cause progressive irreversible visual loss and optic atrophy. The treatment approach depends on the severity and time course of symptoms and visual loss, as determined by formal visual field testing. The main goals of treatment are alleviation of symptoms, including headache, and preservation of vision. All overweight IIH patients should be encouraged to enter a weight-management program with a goal of 5-10 % weight loss, along with a low-salt diet. When there is mild visual loss, medical treatment with acetazolamide should be initiated. Other medical treatments can be added or substituted when acetazolamide is insufficient as monotherapy or poorly tolerated. When visual loss is more severe or rapidly progressive, surgical interventions, such as optic nerve sheath fenestration or cerebrospinal fluid shunting, may be required to prevent further irreversible visual loss. The choice of intervention depends on the relative severity of symptoms and visual loss, as well as local expertise. At present, the role of transverse venous sinus stenting remains unclear. Although there are no evidence-based data to guide therapy, there is an ongoing randomized double-blind placebo-controlled treatment trial, investigating diet and acetazolamide therapy for IIH.
Authors:
Matthew J Thurtell; Michael Wall
Related Documents :
322545 - A comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromus...
1388425 - Congestive heart failure and cardiac thrombus as first presentations of friedreich ataxia.
15109445 - Experimental study on the mechanism of sex difference in the risk of torsade de pointes.
22001745 - Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidati...
8836745 - The effect of suction catheter insertion and tracheal stimulation in adults with severe...
3089495 - Plasma cholesterol concentration and death from coronary heart disease: 10 year results...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in neurology     Volume:  15     ISSN:  1092-8480     ISO Abbreviation:  Curr Treat Options Neurol     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-24     Completed Date:  2013-01-25     Revised Date:  2014-02-03    
Medline Journal Info:
Nlm Unique ID:  9815940     Medline TA:  Curr Treat Options Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1-12     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
U10 EY017281/EY/NEI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Next Document:  Photochemical Evidence of Electronic Interwall Communication in Double-Wall Carbon Nanotubes.